7 research outputs found
Relación entre Medidas Zoométricas en Vacas Holstein-Friesian y Dimensiones de Cubículos en Granjas Lecheras
Body measurements in Portuguese Holstein-Friesian breed and its association with the dimensions of the cubicles
were investigated. During a period of 5 months, body measurements and cubicles size data from 55 commercial Portuguese dairy herds
were collected including in total 1054 individual cows. Data were analyzed using the general linear model and principal components.
The most relevant body measurements were: height at withers (141.1±4.72 cm), height at rump (144.2±4.47 cm), length of trunk (170.8±8.31
cm), width of biiliac (55.9±4.17 cm) and perimeter of the thorax (206.8±10.43 cm). In general, the first class of parity showed significant
different measures (P<0.001) associated with the development of animals. Head to head cubicle length and cubicle width were 223.0±11.0
cm and 113.0±5.0 cm respectively; whereas in cubicle against wall length was 227.0±18.0 cm and width 111.0±7.0 cm. The highest
correlations were found for body measures between the different heights and between the height at chest and perimeter of the thorax.
The analysis showed no relation between body measurements and dimensions of the cubicles. Principal component analysis of the
different body measurements and cubicles dimensions expressed 51.4% of the total variability, in which the first factor represented
40.2% and the second factor 11.1%.info:eu-repo/semantics/publishedVersio
Overview of cattle diseases listed under category C, D or E in the animal health law for wich control programmes are in place within Europe
13 páginas, 5 figuras, 3 tablas.The COST action “Standardising output-based surveillance to control non-regulated
diseases of cattle in the European Union (SOUND control),” aims to harmonise the results
of surveillance and control programmes (CPs) for non-EU regulated cattle diseases to
facilitate safe trade and improve overall control of cattle infectious diseases. In this paper
we aimed to provide an overview on the diversity of control for these diseases in Europe.
A non-EU regulated cattle disease was defined as an infectious disease of cattle with no
or limited control at EU level, which is not included in the European Union Animal health
law Categories A or B under Commission Implementing Regulation (EU) 2020/2002.
A CP was defined as surveillance and/or intervention strategies designed to lower the
incidence, prevalence, mortality or prove freedom from a specific disease in a region
or country. Passive surveillance, and active surveillance of breeding bulls under Council
Directive 88/407/EEC were not considered as CPs. A questionnaire was designed to
obtain country-specific information about CPs for each disease. Animal health experts
from 33 European countries completed the questionnaire. Overall, there are 23 diseases
for which a CP exists in one or more of the countries studied. The diseases for which
CPs exist in the highest number of countries are enzootic bovine leukosis, bluetongue,
infectious bovine rhinotracheitis, bovine viral diarrhoea and anthrax (CPs reported by
between 16 and 31 countries). Every participating country has on average, 6 CPs
(min–max: 1–13) in place. Most programmes are implemented at a national level (86%)
and are applied to both dairy and non-dairy cattle (75%). Approximately one-third
of the CPs are voluntary, and the funding structure is divided between government
and private resources. Countries that have eradicated diseases like enzootic bovine
leukosis, bluetongue, infectious bovine rhinotracheitis and bovine viral diarrhoea have
implemented CPs for other diseases to further improve the health status of cattle in their
country. The control of non-EU regulated cattle diseases is very heterogenous in Europe.
Therefore, the standardising of the outputs of these programmes to enable comparison
represents a challenge.Peer reviewe
What variables are important in predicting bovine viral diarrhea virus? A random forest approach
Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
Aim: Urokinase plasminogen activator (uPA) has been scarcely studied in veterinary oncology. The aim of this study was to determine the uPA serum concentrations in healthy and oncologic canine patients and to investigate its potential value as a tumor biomarker.
Materials and Methods: Serum uPA concentrations of healthy and oncologic canine patients were measured by enzyme-linked immunosorbent assay. Their relationships with the dogs' health status and tumor characteristics were analyzed through ANOVA and independent t-test.
Results: There were no significant differences between mean serum values (±standard deviation) of healthy dogs (0.19±0.13 ng/ml) and oncologic canine patients (0.22±0.33 ng/ml), or between dogs with benign or malignant tumors, and with or without metastases, although the latter tended to show higher uPA serum levels.
Conclusion: This is the first study describing the uPA serum levels in dogs. Although its results do not support uPA as a tumor biomarker, higher uPA levels in dogs with metastatic neoplasms may reflect the role of the enzyme in tumor progression
Bovine viral diarrhoea virus seroprevalence and vaccination usage in dairy and beef herds in the Republic of Ireland
Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe
The COST action “Standardising output-based surveillance to control non-regulated diseases of cattle in the European Union (SOUND control),” aims to harmonise the results of surveillance and control programmes (CPs) for non-EU regulated cattle diseases to facilitate safe trade and improve overall control of cattle infectious diseases. In this paper we aimed to provide an overview on the diversity of control for these diseases in Europe. A non-EU regulated cattle disease was defined as an infectious disease of cattle with no or limited control at EU level, which is not included in the European Union Animal health law Categories A or B under Commission Implementing Regulation (EU) 2020/2002. A CP was defined as surveillance and/or intervention strategies designed to lower the incidence, prevalence, mortality or prove freedom from a specific disease in a region or country. Passive surveillance, and active surveillance of breeding bulls under Council Directive 88/407/EEC were not considered as CPs. A questionnaire was designed to obtain country-specific information about CPs for each disease. Animal health experts from 33 European countries completed the questionnaire. Overall, there are 23 diseases for which a CP exists in one or more of the countries studied. The diseases for which CPs exist in the highest number of countries are enzootic bovine leukosis, bluetongue, infectious bovine rhinotracheitis, bovine viral diarrhoea and anthrax (CPs reported by between 16 and 31 countries). Every participating country has on average, 6 CPs (min–max: 1–13) in place. Most programmes are implemented at a national level (86%) and are applied to both dairy and non-dairy cattle (75%). Approximately one-third of the CPs are voluntary, and the funding structure is divided between government and private resources. Countries that have eradicated diseases like enzootic bovine leukosis, bluetongue, infectious bovine rhinotracheitis and bovine viral diarrhoea have implemented CPs for other diseases to further improve the health status of cattle in their country. The control of non-EU regulated cattle diseases is very heterogenous in Europe. Therefore, the standardising of the outputs of these programmes to enable comparison represents a challenge. © Copyright © 2021 Hodnik, Acinger-Rogić, Alishani, Autio, Balseiro, Berezowski, Carmo, Chaligiannis, Conrady, Costa, Cvetkovikj, Davidov, Dispas, Djadjovski, Duarte, Faverjon, Fourichon, Frössling, Gerilovych, Gethmann, Gomes, Graham, Guelbenzu, Gunn, Henry, Hopp, Houe, Irimia, Ježek, Juste, Kalaitzakis, Kaler, Kaplan, Kostoulas, Kovalenko, Kneževič, Knific, Koleci, Madouasse, Malakauskas, Mandelik, Meletis, Mincu, Mõtus, Muñoz-Gómez, Niculae, Nikitović, Ocepek, Tangen-Opsal, Ózsvári, Papadopoulos, Papadopoulos, Pelkonen, Polak, Pozzato, Rapaliuté, Ribbens, Niza-Ribeiro, Roch, Rosenbaum Nielsen, Saez, Nielsen, van Schaik, Schwan, Sekovska, Starič, Strain, Šatran, Šerić-Haračić, Tamminen, Thulke, Toplak, Tuunainen, Verner, Vilček, Yildiz and Santman-Berends
Corrigendum: Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe (Front. Vet. Sci., (2021), 8, (688078), 10.3389/fvets.2021.688078)
In the original article, there was an error. We used the phrase “non-regulated” for cattle diseases that are in fact listed in the New Animal Health Law that went into force in 2021. A correction has beenmade toAbstract. The corrected section is shown below. Copyright © 2022, Hodnik, Acinger-Rogić, Alishani, Autio, Balseiro, Berezowski, Carmo, Chaligiannis, Conrady, Costa, Cvetkovikj, Davidov, Dispas, Djadjovski, Duarte, Faverjon, Fourichon, Frössling, Gerilovych, Gethmann, Gomes, Graham, Guelbenzu, Gunn, Henry, Hopp, Houe, Irimia, Ježek, Juste, Kalaitzakis, Kaler, Kaplan, Kostoulas, Kovalenko, Kneževič, Knific, Koleci, Madouasse, Malakauskas, Mandelik, Meletis, Mincu, Mõtus, Muñoz-Gómez, Niculae, Nikitović, Ocepek, Tangen-Opsal, Ózsvári, Papadopoulos, Papadopoulos, Pelkonen, Polak, Pozzato, Rapaliuté, Ribbens, Niza-Ribeiro, Roch, Rosenbaum Nielsen, Saez, Nielsen, van Schaik, Schwan, Sekovska, Starič, Strain, Šatran, Šerić-Haračić, Tamminen, Thulke, Toplak, Tuunainen, Verner, Vilček, Yildiz and Santman-Berends